自身炎症性复发性发热的分类标准
Eurofever项目旨在为遗传性复发性发热(HRF)及PFAPA制定并验证基于证据的新分类标准。通过多步骤共识流程,最终标准在HRF中灵敏度0.94-1、特异度0.95-1,PFAPA灵敏度0.97、特异度0.93,独立验证准确度0.81-0.98。
要点
- 新分类标准覆盖FMF、TRAPS、MKD、CAPS及PFAPA,每病种含遗传+临床和仅临床两套标准。
- HRF标准灵敏度0.94-1、特异度0.95-1;PFAPA灵敏度0.97、特异度0.93。
- 独立数据集1018例验证显示准确度0.81-0.98。
核心结论
- Eurofever提出了经过验证的HRF和PFAPA分类标准,具有高灵敏度和特异度。
研究设计与样本
- 分五步:候选变量选择、360例Eurofever登记患者由25名临床医生和8名遗传学家盲法分类(共识≥80%)、统计分析、33名专家共识会议、横断面验证。
- 验证在独立数据集1018例患者中进行。
主要发现
- 专家小组对360例中281例(78%)达成分类共识,包括32例CAPS、36例FMF、56例MKD、37例PFAPA、39例TRAPS和81例未定义复发性发热。
- 为每种HRF制定了两套标准(含遗传和临床变量、仅临床变量),并为PFAPA制定了新标准。
- HRF标准灵敏度0.94-1、特异度0.95-1;PFAPA标准灵敏度0.97、特异度0.93。
- 独立验证准确度范围为0.81至0.98。
关键数值与推荐
- HRF分类标准灵敏度0.94-1、特异度0.95-1。
- PFAPA分类标准灵敏度0.97、特异度0.93。
- 独立验证数据集1018例,准确度0.81-0.98。
临床怎么用
- 可依据新分类标准对HRF和PFAPA患者进行临床分类,标准包含遗传和临床变量或仅临床变量两种版本。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Different diagnostic and classification criteria are available for hereditary recurrent fevers (HRF)-familial Mediterranean fever (FMF), tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), mevalonate kinase deficiency (MKD) and cryopyrin-associated periodic syndromes (CAPS)-and for the non-hereditary, periodic fever, aphthosis, pharyngitis and adenitis (PFAPA). We aimed to develop and validate new evidence-based classification criteria for HRF/PFAPA. METHODS: Step 1: selection of clinical, laboratory and genetic candidate variables; step 2: classification of 360 random patients from the Eurofever Registry by a panel of 25 clinicians and 8 geneticists blinded to patients' diagnosis (consensus ≥80%); step 3: statistical analysis for the selection of the best candidate classification criteria; step 4: nominal group technique consensus conference with 33 panellists for the discussion and selection of the final classification criteria; step 5: cross-sectional validation of the novel criteria. RESULTS: The panellists achieved consensus to classify 281 of 360 (78%) patients (32 CAPS, 36 FMF, 56 MKD, 37 PFAPA, 39 TRAPS, 81 undefined recurrent fever). Consensus was reached for two sets of criteria for each HRF, one including genetic and clinical variables, the other with clinical variables only, plus new criteria for PFAPA. The four HRF criteria demonstrated sensitivity of 0.94-1 and specificity of 0.95-1; for PFAPA, criteria sensitivity and specificity were 0.97 and 0.93, respectively. Validation of these criteria in an independent data set of 1018 patients shows a high accuracy (from 0.81 to 0.98). CONCLUSION: Eurofever proposes a novel set of validated classification criteria for HRF and PFAPA with high sensitivity and specificity.
引用
- Gattorno M, Hofer M, Federici S, et al. Classification criteria for autoinflammatory recurrent fevers. Ann Rheum Dis. 2019. PMID: 31018962. doi:10.1136/annrheumdis-2019-215048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。